Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.45 |
| ▸ | CES2 | O00748 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | PPARD | Q03181 | 2/20 | 0.33 |
| ▸ | PPARA | Q07869 | 2/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL10986319 | 0.91 | ALDH1A1 (0.45) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL4791139 | 0.90 | CES2 (0.48) | CES1CES2ALDH1A1TSHRAKR1B1 | |
| SCHEMBL27912995 | 0.88 | CES1 (0.41) | CES1CES2ALDH1A1TP53CA1 | |
| Ammonia Solution, Strong SCHEMBL4627589 | 0.86 | CES1 (0.50) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL11068780 | 0.84 | CES2 (0.52) | CES1CES2ALDH1A1TSHRTHRB | |
| SCHEMBL11068782 | 0.84 | CES2 (0.52) | CES1CES2ALDH1A1TSHRTHRB | |
| SCHEMBL10474453 | 0.81 | CES1 (0.42) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL453159 | 0.81 | CES1 (0.41) | CES1CES2ALDH1A1TP53CA1 | |
| SCHEMBL10349515 | 0.80 | CES2 (0.55) | CES1CES2ALDH1A1TSHRTHRB | |
| SCHEMBL8845242 | 0.79 | TSHR (0.40) | CES1CES2ALDH1A1TP53CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | claimed |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2022-06-09 | — | — | US | claimed |
| EP-3938359-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2022-01-19 | — | — | EP | claimed |
| WO-2020186077-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2020-09-17 | — | — | WO | claimed |
| US-7678870-B2 | Processable molecularly imprinted polymers | THE JOHNS HOPKINS UNIVERSITY (US) | 2010-03-16 | — | — | US | claimed |
| US-20070197746-A1 | Processable molecularly imprinted polymers | THE JOHNS HOPKINS UNIVERSITY | 2007-08-23 | — | — | US | claimed |
| EP-1733211-A4 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | UNIV JOHNS HOPKINS (US) | 2007-05-30 | — | — | EP | claimed |
| EP-1733211-A1 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | THE JOHNS-HOPKINS UNIVERSITY (US) | 2006-12-20 | — | — | EP | claimed |
| WO-2005103655-A1 | PROCESSABLE MOLECULARLY IMPRINTED POLYMERS | THE JOHNS HOPKINS UNIVERSITY (US) | 2005-11-03 | — | — | WO | claimed |
| US-20240181430-A1 | POROUS SORPTIVE SOLID PHASE MICROEXTRACTION DEVICES AND PREPARATION THEREOF | MEMORIAL UNIVERSITY OF NEWFOUNDLAND (CA) | 2024-06-06 | — | — | US | disclosed |
| EP-4294559-A1 | POROUS SORPTIVE SOLID PHASE MICROEXTRACTION DEVICES AND PREPARATION THEREOF | Memorial University of Newfoundland (CA) | 2023-12-27 | — | — | EP | disclosed |
| WO-2023056310-A1 | MOLECULARLY IMPRINTED POLYMER COATINGS AND SENSORS FOR BIODETECTION | 6th Wave Innovations Corp. (US) | 2023-04-06 | — | — | WO | disclosed |
| US-20230103369-A1 | THE USE OF MOLECULARLY IMPRINTED POLYMERS FOR THE RAPID DETECTION OF EMERGING VIRAL OUTBREAKS | ORCA HOLDINGS, LLC | 2023-04-06 | — | — | US | disclosed |
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | disclosed |
| WO-2001077672-A2 | MOLECULARLY IMPRINTED POLYMER BASED SENSORS FOR THE DETECTION OF NARCOTICS | THE JOHNS HOPKINS UNIVERSITY (US) | 2001-10-18 | — | — | WO | disclosed |
| WO-2001077664-A2 | MOLECULARLY IMPRINTED POLYMERIC SENSOR FOR THE DETECTION OF EXPLOSIVES | THE JOHNS HOPKINS UNIVERSITY (US) | 2001-10-18 | — | — | WO | disclosed |
| US-5858296-A | A BIOLOGICALLY ACTIVE MOLECULE FORMED BY POLYMERIZATION OF FUNCTIONAL MONOMERS AROUND A TEMPLATE MOLECULE THAT EXHIBITS DRUG ACTIVITY, REMOVAL OF TEMPLATE AND POLYMERIZATION OF SECOND CLASS OF MONOMER IN THE VOIDS LEFT BY TEMPLATE | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1999-01-12 | — | — | US | disclosed |
| US-5630978-A | POLYMERIZATION OF FUNCTIONAL MONOMERS AROUND A BIOLOGICALLY ACTIVE TEMPLATE MOLECULE, REMOVAL OF TEMPLATE TO LEAVE A VOID, THEN POLYMERIZATION OF OTHER MONOMER(S) IN THE VOID | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1997-05-20 | — | — | US | disclosed |
| WO-1996040822-A1 | PREPARATION OF BIOLOGICALLY ACTIVE MOLECULES BY MOLECULAR IMPRINTING | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1995032736-A1 | IMMOBILIZATION OF BIOLOGICALLY ACTIVE MATERIALS AND DIAGNOSTIC AGENTS IN CROSS-LINKED POLY(ORGANOPHOSPHAZENES) | THE PENN STATE RESEARCH FOUNDATION (US) | 1995-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | CES1 1853/4885CES2 33/4885ALDH1A1 3487/4885 |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | CES1 1853/4885CES2 33/4885ALDH1A1 3487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.